“Lipids: going beyond LDL-C” | This session is organised and funded by Recordati Pharmaceuticals Limited
Dr Narain will look at the evidence of going beyond LDL cholesterol when reducing patients risk from Lipids and how clinicians may improve patients’ outcomes in secondary prevention. He will review the latest guidelines and discuss how to effectively implement them in practice.
Dr Rajay Narain has received a speaker honorarium from Recordati for this presentation.

